NICE type 1 diabetes guideline
This summary on type 1 diabetes in adults covers diagnosis, insulin therapy, and blood glucose management, and includes a useful algorithm
NICE type 2 diabetes guideline
This updated summary provides recommendations on blood glucose targets, and includes a useful algorithm on blood glucose management
NICE type 2 diabetes prevention guideline
This Guidelines summary covers the identification of people at high risk of type 2 diabetes and the provision of interventions for them
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.
![20210603 Guidelines comparison table [online]](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67/0/0/0/10000_20210603guidelinescomparisontableonline_766677.png)
Type 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN
NICE diabetes in pregnancy guideline
An up-to-date summary of NICE guidance on diabetes management in pregnancy. Includes gestational diabetes, preconception, antenatal, and postnatal care.
KDIGO guideline on diabetes management in CKD
Recommendations on comprehensive care, glycaemic monitoring and targets, lifestyle and antihyperglycaemic interventions, and approaches to self-management and optimal models of care
Diabetic foot problems: prevention and management
This summary covers preventing and managing foot problems in children, young people, and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
A top tips guide to biosimilar insulins
Karen Bartha shares her top tips on prescribing considerations for biosimilars such as stability, interchangeability/switching, and brand names.
Resource hub
Educational resources
Best practice treatment and management of patients with type 2 diabetes, cardiovascular disease, and heart failure
This management algorithm was developed by a multidisciplinary expert panel: Javaid et al with the support of an educational grant from AstraZeneca. Information intended for UK healthcare professionals.
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
Pancreatic exocrine insufficiency guideline
This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.